clindamycin has been researched along with Bacterial Vaginitides in 155 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 42 (27.10) | 18.2507 |
| 2000's | 60 (38.71) | 29.6817 |
| 2010's | 36 (23.23) | 24.3611 |
| 2020's | 17 (10.97) | 2.80 |
| Authors | Studies |
|---|---|
| Bradshaw, CS; Bulach, DM; Chow, EPF; Danielewski, JA; Doyle, M; Fairley, CK; Fehler, G; Garland, SM; Hocking, JS; Murray, GL; Plummer, EL; Vodstrcil, LA | 1 |
| Holzgreve, W; Mendling, W | 1 |
| Castro, J; Cerca, N; França, A; Rosca, AS; Sousa, LGV; Vaneechoutte, M | 1 |
| Cerca, N | 1 |
| An, R; Cao, Y; Fan, S; Feng, H; Hu, L; Li, M; Li, P; Liao, Q; Lv, T; Song, D; Yang, X; Zeng, Z; Zhang, B; Zhang, L; Zhang, Q | 1 |
| Chavoustie, S; Dart, C; Friend, D; Gendreau, J; Hillier, SL; Jacobs, M; Mauck, C; Nicholson-Uhl, C; Perez, B; Sorkin-Wells, V; Zack, N | 1 |
| Slomski, A | 1 |
| Atiee, GJ; Friend, DR; Mauck, CK; McCulloh, J; Reynolds, L; Zack, N | 1 |
| Andrews, WW; Bhandaru, V; Emel, LM; Goldenberg, RL; Hoffman, MK; Kiss, H; Klebanoff, MA; Lamont, RF; Larsen, MD; Larsson, PG; Odendaal, HJ; Petricevic, L; Schuit, E; Seed, PT; Shennan, A; Ugwumadu, A; Weiner, S | 1 |
| Chavoustie, S; Dart, C; Friend, D; Gendreau, J; Hillier, SL; Jacobs, M; Mauck, C; Nicholson-Uhl, CS; Perez, B; Sorkin-Wells, V; Wu, H; Zack, N | 1 |
| Faught, BM; Reyes, S | 1 |
| Eckert, LO; Kus, LH; Neal, CM; Peipert, JF | 1 |
| Berkman, N; Clark, R; Kahwati, LC; Patel, SV; Urrutia, R; Viswanathan, M; Zeng, J | 1 |
| Barnabas, SL; Bekker, LG; Dabee, S; Dietrich, J; Froissart, R; Gamieldien, H; Gray, G; Happel, AU; Jaspan, HB; Jaumdally, SZ; Kullin, B; Passmore, JS; Wentzel, N; Zauchenberger, CZ | 1 |
| Martinez-de-Oliveira, J; Palmeira-de-Oliveira, A; Palmeira-de-Oliveira, R; Simões, S; Tomás, M | 1 |
| Boers, K; Knetsch, CW; Kuijper, EJ; Leverstein-van Hall, MA; Molijn, A; van den Munckhof, EHA; Zwittink, RD | 1 |
| Bateson, D; Bradshaw, CS; Chow, EPF; Donovan, B; Doyle, M; Fairley, CK; Hocking, JS; Law, MG; McGuiness, C; Petoumenos, K; Plummer, EL; Vodstrcil, LA | 1 |
| Pustotina, O | 1 |
| Basharat, A; Fahim, A; Khan, DH; Khan, MH; Tariq, N | 1 |
| Witkin, SS | 1 |
| Bannale, SG; Bellad, MB; Charantimath, US; Derman, RJ; Ganachari, MS; Goudar, SS; Hoffman, MK; Katageri, GM; Kavi, A; Kodkany, BS; Mallapur, AA; Ramdurg, UY; Revankar, AP; Sloan, NL | 1 |
| Hoffman, MK | 1 |
| Jørgensen, JS; Lamont, RF; Luef, BM | 1 |
| Ancel, PY; Bissinger, MC; Brabant, G; Canis, F; Chantrel, J; Deghilage, S; Delaeter, C; Desseauve, D; Dessein, R; Devos, P; Dugimont, JC; Faure, K; Fruchart, A; Gautier, S; Goffinet, F; Grandbastien, B; Guinard, E; Hacot, C; Jousse, M; Joyez, E; Kipnis, E; Nolf, C; Personne, A; Plennevaux, JL; Subtil, D; Tilloy, E | 1 |
| Brotman, RM; Klebanoff, MA | 1 |
| Abdeldayem, H; Elsharkawy, I; Mansour, SAM; Mohamed, A; Mohamed, E; Noureldin, E | 1 |
| Cobucci, RN; Costa, APF; Eleutério, J; Gonçalves, AK; Peixoto, RC; Rebouças, KF | 1 |
| Dobrevski-Vacheva, R; Kovachev, S | 1 |
| Donders, GG; Rezeberga, D; Zodzika, J | 1 |
| Cavera, VL; Chikindas, ML; Volski, A | 1 |
| van Schalkwyk, J; Yudin, MH | 1 |
| Brandsborg, E; Hammarström, L; Larsson, PG; Marcotte, H; Pendharkar, S | 1 |
| D'Alterio, M; Marotto, MF; Melis, GB; Orrù, MM; Paoletti, AM; Pilloni, M; Zedda, P | 1 |
| Ersbøll, AS; Haahr, T; Hee, L; Helmig, RB; Jensen, JS; Karlsen, MA; Sneider, K; Svare, J; Uldbjerg, N; Weile, LK; Ziobrowska-Bech, A; Østergaard, C | 1 |
| Amaya-Guio, J; Grillo-Ardila, CF; Martinez-Velasquez, MY; Sierra-Barrios, EM; Viveros-Carreño, DA | 1 |
| Jørgensen, JS; Keelan, JA; Lamont, RF; Larsson, PG | 1 |
| Schwebke, J | 1 |
| Milánkovits, M | 1 |
| Gupta, P | 1 |
| Anorlu, RI; Oduyebo, OO; Ogunsola, FT | 1 |
| Arechavaleta-Velasco, F; Cuica-Flores, A; Diaz-Cueto, L; Dominguez-Lopez, P; Rosales-Ortiz, S; Tena-Alavez, G | 1 |
| Beigi, RH; Bunge, KE; Hillier, SL; Meyn, LA | 1 |
| Damjanov, L | 1 |
| Botta, GA; Senok, AC; Temmerman, M; Verstraelen, H | 1 |
| Beigi, RH; Chen, JY; Tian, H | 1 |
| Battini, V; Bulgheroni, A; Caserini, M; Mailland, F; Mendling, W; Togni, G | 1 |
| Gibson, MV; Hainer, BL | 1 |
| Eriksson, K; Forsum, U; Larsson, PG; Nilsson, M | 1 |
| Aram, S; Borna, S; Golshahi, F; Hantoushzadeh, S; Hashemi, S; Javadian, P; Khazardoost, S; Mirarmandehi, B | 1 |
| Andersen, KK; Brandsborg, E; Forsum, U; Hammarström, L; Larsson, PG; Marcotte, H; Nasic, S; Pendharkar, S | 1 |
| Bravo-Topete, EG; Cejudo-Alvarez, J; Garibay-Valencia, M; Herrera-Villalobos, JE; Martínez-García, A; Mirabent-González, F | 1 |
| Conde-Agudelo, A; Lamont, RF; Nhan-Chang, CL; Romero, R; Sobel, JD; Workowski, K | 1 |
| Polatti, F | 1 |
| Donders, G; Gerber, S; Halaška, M; Martinez de Tejada, B; Špaček, J; Unzeitig, V; Weissenbacher, ER | 1 |
| Heczko, PB; Strus, M; Tomusiak, A | 1 |
| Grob, P; Lopes dos Santos Santiago, G; Vaneechoutte, M; Verstraelen, H; Waser, F | 1 |
| Dimitrov, A; Nikolov, A; Shopova, E | 1 |
| Bradshaw, CS; De Guingand, D; Fairley, CK; Fehler, G; Garland, SM; Hocking, JS; Morrow, A; Morton, AN; Pirotta, M; Vodstrcil, LA; Walker, S | 1 |
| Bassett, P; Lamont, RF; Taylor-Robinson, D | 1 |
| Bradshaw, CS; De Guingand, D; Fairley, CK; Garland, SM; Hocking, JS; Law, M; Morton, AN; Pirotta, M; Vodstrcil, LA | 1 |
| Marrazzo, JM | 1 |
| Fritz, G; Gaudineau, A; Langer, B; Sananes, N | 1 |
| Hogan, V; Koumans, EH; Markowitz, LE | 1 |
| Fang, F; Han, Z; Huang, W; Huang, X; Li, S; Peng, Y; Qiao, L; Su, Y; Zhou, R; Zhou, S; Zhou, X | 1 |
| Lamont, RF; Morgan, DJ; Rosenstein, IJ; Sheehan, M; Taylor-Robinson, D | 1 |
| Hay, P; Manyonda, I; Reid, F; Ugwumadu, A | 2 |
| Agnello, A; Barcellona, E; Milani, M | 1 |
| Althabe, F; Barros, FC; Belizán, JM; Bergel, E | 1 |
| Athayde, N; Gilbert, G; Isaacs, D; Stanley, F; Tarnow-Mordi, W | 1 |
| Lamont, DF | 1 |
| Callahan, DB; Gunn, RA; Weinberg, M | 1 |
| Benedetto, C; Franchi, M; Frate, GD; Ghezzi, F; Guaschino, S; Parazzini, F; Ricci, E; Santo, DD; Seta, FD; Tibaldi, C | 1 |
| Hoyme, UB; Saling, E | 2 |
| Kekki, M; Kotomäki, T; Kurki, T; Paavonen, J; Sintonen, H | 1 |
| Hay, PE | 2 |
| Hay, PE; Jones, BM; Lamont, RF; Mandal, D; Sheehan, M | 1 |
| Braverman, PK; Syed, TS | 1 |
| Austin, MN; Beigi, RH; Hillier, SL; Krohn, MA; Meyn, LA | 1 |
| Kotsuji, F; Nishijima, K; Shukunami, K | 1 |
| Damianov, L; Damianova, V | 1 |
| French, L; Horton, J; Matousek, M | 1 |
| Carlsson, B; Eriksson, K; Forsum, U; Larsson, PG | 1 |
| Bergström, M; Forsum, U; Jacobsson, B; Larsson, PG; Strand, A; Wölner-Hanssen, P | 1 |
| Austin, MN; Beigi, RH; Hillier, SL; Meyn, LA | 1 |
| Faro, S; Skokos, CK | 1 |
| Garibay, M; Godínez, V; Mirabent, F; Pérez Calderón, A | 1 |
| Hay, P; Jeffrey, I; Manyonda, I; Reid, F; Ugwumadu, A | 1 |
| Gattermeir, DJ; Joffrion, JL; McIntosh, MJ; Nyirjesy, P; Schumacher, RJ; Steinmetz, JI | 1 |
| Carlsson, B; Fåhraeus, L; Forsum, U; Jakobsson, T; Larsson, PG | 2 |
| Joffrion, JL; McIntosh, MJ; Nyirjesy, P; Schumacher, RJ; Steinmetz, JI | 1 |
| Bujold, E; Morency, AM | 2 |
| Alpay Karaoğlu, S; Aydin, F; Buruk, CK; Ciftçi, H; Ertürk, M; Kiliç, AO; Tosun, I | 1 |
| Ugwumadu, A | 1 |
| Darwish, A; Elnshar, EM; Hamadeh, SM; Makarem, MH | 1 |
| Alqumber, MA; Burton, JP; De Backer, E; Tagg, JR; Temmerman, M; Vaneechoutte, M; Verhelst, R; Verstraelen, H | 1 |
| Larsen, S; Larsson, PG; Ryttig, KR; Stray-Pedersen, B | 1 |
| Rousson, V; Seifert, B | 1 |
| Spaulding, C | 1 |
| Hillier, SL; Idajadi, A; Joesoef, MR; Linnan, M; Norojono, W; Sumampouw, H; Utomo, B; Wiknjosastro, G | 1 |
| Batts, DH; Borin, MT; Powley, GW; Tackwell, KR | 1 |
| Ahmed-Jushuf, IH; Arya, OP; Shahmanesh, M | 1 |
| Ferris, DG; Hendrich, J; Litaker, MS; Mathis, D; Woodward, L | 1 |
| Forrest, KA | 1 |
| Katz, VL; Killam, AP; Kuller, JA; Livengood, CH; McCoy, MC | 1 |
| Beltrán, M; Casanova, G; Higuera, F; Luis Arredondo, J; Narcio, ML | 1 |
| Hill, GB; Livengood, CH | 1 |
| Schlicht, JR | 1 |
| French, JI; Jones, W; McGregor, JA; McKinney, PJ; Milligan, K; Parker, R; Patterson, E | 1 |
| Alawattegama, AB; Arya, OP; Dhar, J; Moss, S; Mukembo, S; Timmins, DJ; Williams, O | 1 |
| Christensen, SL; Mummaw, NL; Soper, DE; Stein, GE | 1 |
| Fischbach, F; Hosmann, J; Martius, J; Mayer, H; Petersen, EE; Weissenbacher, ER | 1 |
| Sweet, RL | 1 |
| Meriwether, C; Schmitt, C; Sobel, JD | 2 |
| Gómez, R; Montiel, F; Oyarzún, E | 1 |
| Altrichter, T; Heizmann, WR | 1 |
| Adu-Sarkodie, YA; Atia, WA; Bendall, R; Brook, MG; Clark, S; Kell, PD; Kelsey, MC | 1 |
| Kinghorn, GR; Priestley, CJ | 1 |
| Beltrán, M; Casanova Roman, G; Flores Rivera, E; González Jimenez, MA; Villegas Castrejon, H | 1 |
| Fraser, TG; Jones, MP; Trexler, MF | 1 |
| Colli, E; Landoni, M; Parazzini, F | 1 |
| Majeroni, BA | 2 |
| Diaz, PR; Latham, GS; Meadowcroft, AM | 1 |
| Bazarra Fernández, A; Castro Iglesias, A | 1 |
| Battaglia, F; De Vincenzo, R; Distefano, M; Foti, E; Lopez, R; Mancuso, S; Margariti, PA; Masciullo, V; Panici, PB; Scambia, G; Scirpa, P | 1 |
| Gardó, S | 1 |
| Kekki, M; Kurki, T; Paavonen, J; Rutanen, EM | 1 |
| Berger, K; Dennemark, N; Müller, E; Oleen-Burkey, M | 1 |
| Borisov, I; Dimitrova, V; Mazneĭkova, V; Shopova, E | 1 |
| Dalaker, K; Eriksson, K; Fåhraeus, L; Irminger, K; Jerve, F; Larsson, PG; Platz-Christensen, JJ; Stray-Pedersen, B; Wölner-Hanssen, P | 1 |
| Mangioni, C; Martin, MA; Paavonen, J; Wajszczuk, CP | 1 |
| Bozhinova, S; POrozhanova, V | 1 |
| Doré, CJ; Hay, PE; Lamont, RF; Morgan, DJ; Rosenstein, IJ; Sheehan, M; Taylor-Robinson, D | 1 |
| Jouppila, P; Kekki, M; Koskela, M; Kurki, T; Kurkinen-Räty, M; Paavonen, J; Vuopala, S | 1 |
| Cacciatore, B; Kekki, M; Kurki, T; Kurkinen-Räty, M; Paavonen, J; Pelkonen, J | 1 |
| Kane, KY; Pierce, R | 1 |
| Livengood, C; Martin, M; McGregor, JA; Peipert, JF; Robbins, J; Sobel, J; Wajszczuk, CP | 1 |
| Bruinse, HW; van Zwet, AA; Vermeulen, GM | 1 |
| Covino, JM; Eschenbach, DA; Hillier, SL; Kapernick, P; McCormack, WM; McGregor, J; Mou, S; Rein, MF; Thomason, JL | 1 |
| Heimrath, J; Hirnle, G; Hirnle, L; Kłósek, A; Małolepsza-Jarmołowska, K; Woytoń, J | 1 |
| Borisov, I | 1 |
| Einarson, A; Koren, G | 1 |
| Andres, FJ; Benrubi, GI; Hosein, I; Parker, R | 1 |
| Edwards, MS; Harris, JH; Honkanen, AA; Raia, TJ; Schell, CL | 1 |
| French, JI; McGregor, JA; Seo, K | 1 |
| Gelbart, SM; Scaglione, NJ; Thomason, JL | 1 |
34 review(s) available for clindamycin and Bacterial Vaginitides
| Article | Year |
|---|---|
Astodrimer sodium and bacterial vaginosis: a mini review.
Topics: Anti-Bacterial Agents; Bacteria; Clindamycin; Dendrimers; Female; Humans; Metronidazole; Polylysine; Pregnancy; Vaginosis, Bacterial | 2022 |
Antibiotic treatment of bacterial vaginosis to prevent preterm delivery: Systematic review and individual participant data meta-analysis.
Topics: Anti-Bacterial Agents; Clindamycin; Female; Humans; Infant, Newborn; Metronidazole; Pregnancy; Premature Birth; Vaginosis, Bacterial | 2023 |
Characterization and Treatment of Recurrent Bacterial Vaginosis.
Topics: Anti-Bacterial Agents; Antiprotozoal Agents; Clindamycin; Female; Humans; Metronidazole; Recurrence; Treatment Outcome; Vaginosis, Bacterial | 2019 |
Noncandidal vaginitis: a comprehensive approach to diagnosis and management.
Topics: Administration, Intravaginal; Administration, Oral; Anti-Infective Agents; Anti-Inflammatory Agents; Atrophic Vaginitis; Candidiasis, Vulvovaginal; Clindamycin; Dehydroepiandrosterone; Diagnosis, Differential; Estrogen Replacement Therapy; Estrogens; Female; Humans; Hydrocortisone; Inflammation; Lichen Planus; Metronidazole; Pemphigoid, Benign Mucous Membrane; Pemphigoid, Bullous; Pemphigus; Tamoxifen; Tinidazole; Trichomonas Vaginitis; Vaginitis; Vaginosis, Bacterial | 2020 |
Screening for Bacterial Vaginosis in Pregnant Adolescents and Women to Prevent Preterm Delivery: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
Topics: Anti-Bacterial Agents; Asymptomatic Infections; Clindamycin; Female; Humans; Mass Screening; Metronidazole; Practice Guidelines as Topic; Pregnancy; Pregnancy Complications, Infectious; Premature Birth; Risk Factors; Vaginosis, Bacterial | 2020 |
Bacterial vaginosis: Standard treatments and alternative strategies.
Topics: Anti-Bacterial Agents; Clindamycin; Female; Humans; Lactobacillus; Metronidazole; Probiotics; Vagina; Vaginosis, Bacterial | 2020 |
Treatment of bacterial vaginosis before 28 weeks of pregnancy to reduce the incidence of preterm labor.
Topics: Administration, Intravaginal; Administration, Oral; Anti-Bacterial Agents; Clindamycin; Female; Humans; Incidence; Infant, Newborn; Metronidazole; Obstetric Labor, Premature; Pregnancy; Pregnancy Complications, Infectious; Randomized Controlled Trials as Topic; Vaginosis, Bacterial | 2019 |
Treatment of bacterial vaginosis: what we have and what we miss.
Topics: Anti-Bacterial Agents; Anti-Infective Agents, Local; Clindamycin; Coinfection; Drug Therapy, Combination; Female; Humans; Metronidazole; Prebiotics; Probiotics; Secondary Prevention; Vaginosis, Bacterial | 2014 |
Treatment of bacterial vaginosis in pregnancy in order to reduce the risk of spontaneous preterm delivery - a clinical recommendation.
Topics: Anti-Bacterial Agents; Clindamycin; Female; Humans; Metronidazole; Pregnancy; Pregnancy Complications, Infectious; Premature Birth; Probiotics; Risk Factors; Treatment Outcome; Vaginosis, Bacterial | 2016 |
Antibiotic treatment for the sexual partners of women with bacterial vaginosis.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Clindamycin; Female; Humans; Indazoles; Lincosamides; Male; Metronidazole; Middle Aged; Randomized Controlled Trials as Topic; Recurrence; Secondary Prevention; Sexual Partners; Time Factors; Tinidazole; Vaginosis, Bacterial | 2016 |
The Women's Health II Medical Education Network _Part 1: Understanding bacterial vaginosis: diagnosis, treatment, and improved outcomes.
Topics: Adult; Anti-Bacterial Agents; Clindamycin; Female; Humans; Metronidazole; Pregnancy; Pregnancy Complications, Infectious; Vaginosis, Bacterial; Women's Health | 2007 |
The effects of antimicrobial therapy on bacterial vaginosis in non-pregnant women.
Topics: Anti-Infective Agents; Clindamycin; Female; Humans; Lactobacillus; Metronidazole; Probiotics; Randomized Controlled Trials as Topic; Vaginal Douching; Vaginosis, Bacterial | 2009 |
Probiotics for the treatment of bacterial vaginosis.
Topics: Anti-Bacterial Agents; Clindamycin; Estriol; Female; Humans; Lactobacillus; Probiotics; Randomized Controlled Trials as Topic; Vagina; Vaginosis, Bacterial | 2009 |
Vaginitis.
Topics: Administration, Intravaginal; Administration, Oral; Anti-Bacterial Agents; Anti-Infective Agents; Antifungal Agents; Atrophic Vaginitis; Bacterial Load; Candidiasis, Vulvovaginal; Clindamycin; Estrogens; Female; Gynecological Examination; Humans; Hydrogen-Ion Concentration; Metronidazole; Microscopy; Treatment Outcome; Trichomonas Vaginitis; Vaginal Discharge; Vaginosis, Bacterial | 2011 |
Treatment of abnormal vaginal flora in early pregnancy with clindamycin for the prevention of spontaneous preterm birth: a systematic review and metaanalysis.
Topics: Anti-Bacterial Agents; Clindamycin; Female; Humans; Pregnancy; Pregnancy Complications, Infectious; Premature Birth; Vagina; Vaginosis, Bacterial | 2011 |
Bacterial vaginosis, Atopobium vaginae and nifuratel.
Topics: Actinobacteria; Anti-Bacterial Agents; Clindamycin; Dose-Response Relationship, Drug; Female; Gardnerella vaginalis; Humans; Metronidazole; Microbial Sensitivity Tests; Nifuratel; Secondary Prevention; Vaginosis, Bacterial | 2012 |
Bacterial vaginosis and miscarriage.
Topics: Abortion, Spontaneous; Clindamycin; Female; Humans; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Trimesters; Randomized Controlled Trials as Topic; Vaginosis, Bacterial | 2004 |
Vaginitis in adolescents.
Topics: Adolescent; Anti-Infective Agents; Antifungal Agents; Candidiasis, Vulvovaginal; Clindamycin; Female; Humans; Metronidazole; Physical Examination; Trichomonas Vaginitis; Vaginosis, Bacterial | 2004 |
Abnormal vaginal discharge: what does and does not work in treating underlying causes.
Topics: Anti-Bacterial Agents; Antifungal Agents; Candidiasis, Vulvovaginal; Clindamycin; Female; Humans; Metronidazole; Nonprescription Drugs; Recurrence; Risk Factors; Self Medication; Sexually Transmitted Diseases; Trichomonas Vaginitis; United States; Vaginal Discharge; Vaginal Diseases; Vaginosis, Bacterial; Women's Health | 2004 |
Bacterial vaginosis. Transmission, role in genital tract infection and pregnancy outcome: an enigma.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Clindamycin; Disease Transmission, Infectious; Female; Humans; Meta-Analysis as Topic; Metronidazole; Pelvic Inflammatory Disease; Postoperative Complications; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Risk; Sexually Transmitted Diseases, Bacterial; Vaginosis, Bacterial | 2005 |
Role of antibiotic therapy for bacterial vaginosis and intermediate flora in pregnancy.
Topics: Anti-Bacterial Agents; Clindamycin; Female; Humans; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Vaginosis, Bacterial | 2007 |
Bacterial vaginosis in pregnancy: an approach for the 1990s.
Topics: Clindamycin; Female; Fetal Membranes, Premature Rupture; Gestational Age; Humans; Metronidazole; Obstetric Labor, Premature; Pregnancy; Pregnancy Complications, Infectious; Risk Factors; Vaginitis; Vaginosis, Bacterial | 1995 |
Treatment of bacterial vaginosis.
Topics: Adult; Clindamycin; Clinical Trials as Topic; Female; Gels; Humans; Metronidazole; Pregnancy; Pregnancy Complications, Infectious; Sexual Partners; Sexually Transmitted Diseases; Vaginosis, Bacterial | 1994 |
New approaches for the treatment of bacterial vaginosis.
Topics: Administration, Intravaginal; Administration, Oral; Clindamycin; Female; Humans; Metronidazole; Vaginosis, Bacterial | 1993 |
[Bacterial vaginosis II. Related pathology and therapy].
Topics: Anti-Bacterial Agents; Chorioamnionitis; Clindamycin; Endometritis; Female; Humans; Metronidazole; Obstetric Labor, Premature; Pregnancy; Pregnancy Complications, Infectious; Recurrence; Risk Factors; Salpingitis; Uterine Cervical Dysplasia; Vaginosis, Bacterial | 1995 |
Bacterial vaginosis.
Topics: Anti-Bacterial Agents; Antitrichomonal Agents; Clindamycin; Female; Humans; Metronidazole; Prevalence; Vaginosis, Bacterial | 1996 |
Fulminant pseudomembranous colitis caused by clindamycin phosphate vaginal cream.
Topics: Adolescent; Anti-Bacterial Agents; Clindamycin; Enterocolitis, Pseudomembranous; Female; Humans; Pregnancy; Vaginal Creams, Foams, and Jellies; Vaginosis, Bacterial | 1997 |
Bacterial vaginosis: an update.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Clindamycin; Diagnosis, Differential; Female; Humans; Metronidazole; Patient Education as Topic; Pregnancy; Pregnancy Complications, Infectious; Teaching Materials; Vaginosis, Bacterial | 1998 |
[Therapy of bacterial vaginosis. Prospective clinical study ot the efficacy and tolerability of quaternary ammonium salts vs. clindamycin].
Topics: Adolescent; Adult; Anti-Bacterial Agents; Clindamycin; Female; Humans; Prospective Studies; Quaternary Ammonium Compounds; Vaginosis, Bacterial | 1998 |
[Bacterial vaginosis].
Topics: Anti-Bacterial Agents; Antitrichomonal Agents; Clindamycin; Female; Humans; Metronidazole; Obstetric Labor, Premature; Pelvic Inflammatory Disease; Pregnancy; Pregnancy Complications, Infectious; Puerperal Infection; Vaginosis, Bacterial | 1998 |
Management of bacterial vaginosis.
Topics: Anti-Bacterial Agents; Clindamycin; Female; Humans; Metronidazole; Pregnancy; Pregnancy Complications, Infectious; Vaginosis, Bacterial | 1998 |
Clinical inquiries. What are the most effective treatments for bacterial vaginosis in nonpregnant women?
Topics: Administration, Oral; Adult; Antifungal Agents; Clindamycin; Evidence-Based Medicine; Female; Guidelines as Topic; Humans; Metronidazole; Ofloxacin; Treatment Outcome; Vaginosis, Bacterial | 2001 |
[Current treatment of bacterial vaginosis].
Topics: Administration, Oral; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Anti-Infective Agents; Clindamycin; Female; Humans; Metronidazole; Pregnancy; Pregnancy Complications, Infectious; Secondary Prevention; Time Factors; Vaginal Creams, Foams, and Jellies; Vaginosis, Bacterial | 1999 |
Bacterial vaginosis: current review with indications for asymptomatic therapy.
Topics: Antifungal Agents; Bacteria, Anaerobic; Clindamycin; Female; Gardnerella; Humans; Incidence; Lactobacillus; Metronidazole; Risk Factors; Vaginosis, Bacterial | 1991 |
67 trial(s) available for clindamycin and Bacterial Vaginitides
| Article | Year |
|---|---|
A Prospective, Open-Label Pilot Study of Concurrent Male Partner Treatment for Bacterial Vaginosis.
Topics: Adult; Anti-Bacterial Agents; Bacteria; Clindamycin; Female; Heterosexuality; Humans; Male; Metronidazole; Penis; Pilot Projects; Prospective Studies; Sexual Partners; Vagina; Vaginosis, Bacterial | 2021 |
Accurate 16S Absolute Quantification Sequencing Revealed Vaginal Microecological Composition and Dynamics During Mixed Vaginitis Treatment With Fufang FuRong Effervescent Suppository.
Topics: Clindamycin; Female; Humans; Vagina; Vaginitis; Vaginosis, Bacterial; Vulvovaginitis | 2022 |
Single-Dose, Bioadhesive Clindamycin 2% Gel for Bacterial Vaginosis: A Randomized Controlled Trial.
Topics: Administration, Intravaginal; Anti-Bacterial Agents; Clindamycin; Double-Blind Method; Female; Humans; Treatment Outcome; Vaginal Creams, Foams, and Jellies; Vaginosis, Bacterial | 2022 |
A Phase 1 pharmacokinetic study of a single-dose bioadhesive clindamycin 2% gel for bacterial vaginosis.
Topics: Administration, Oral; Area Under Curve; Clindamycin; Female; Humans; Vaginosis, Bacterial | 2022 |
Acceptability of Single-dose Clindamycin Gel for Bacterial Vaginosis: A Randomized Controlled Trial.
Topics: Administration, Intravaginal; Anti-Bacterial Agents; Clindamycin; Double-Blind Method; Female; Humans; Treatment Outcome; Vaginal Creams, Foams, and Jellies; Vaginosis, Bacterial | 2023 |
Exploring potential of vaginal Lactobacillus isolates from South African women for enhancing treatment for bacterial vaginosis.
Topics: Adolescent; Adult; Bacteroidaceae Infections; Clindamycin; Drug Resistance, Bacterial; Female; Gardnerella vaginalis; Gram-Positive Bacterial Infections; Humans; Hydrogen Peroxide; Lactic Acid; Lactobacillus; Metronidazole; Prevotella; South Africa; Species Specificity; Vaginosis, Bacterial | 2020 |
Treating male partners of women with bacterial vaginosis (StepUp): a protocol for a randomised controlled trial to assess the clinical effectiveness of male partner treatment for reducing the risk of BV recurrence.
Topics: Administration, Intravaginal; Administration, Oral; Anti-Bacterial Agents; Australia; Clindamycin; Female; Follow-Up Studies; Humans; Male; Metronidazole; New Zealand; Penis; Prospective Studies; Recurrence; Sexual Partners; Treatment Outcome; Vaginosis, Bacterial | 2020 |
Effectiveness of dydrogesterone, 17-OH progesterone and micronized progesterone in prevention of preterm birth in women with a short cervix.
Topics: Administration, Intravaginal; Adult; Anti-Bacterial Agents; Cerclage, Cervical; Clindamycin; Drug Therapy, Combination; Female; Hexoprenaline; Humans; Pregnancy; Premature Birth; Probiotics; Progesterone; Progestins; Tocolysis; Tocolytic Agents; Uterine Cervical Incompetence; Vaginosis, Bacterial; Young Adult | 2018 |
Treatment for Symptomatic Bacterial Vaginosis: ARandomized Controlled Trial.
Topics: Administration, Intravaginal; Administration, Oral; Adult; Anti-Bacterial Agents; Antiprotozoal Agents; Clindamycin; Double-Blind Method; Female; Humans; Metronidazole; Vaginal Creams, Foams, and Jellies; Vaginosis, Bacterial | 2017 |
Clindamycin to reduce preterm birth in a low resource setting: a randomised placebo-controlled clinical trial.
Topics: Administration, Oral; Adolescent; Adult; Anti-Bacterial Agents; Clindamycin; Double-Blind Method; Female; Gestational Age; Humans; Incidence; India; Infant, Newborn; Maternal-Child Health Services; Medically Underserved Area; Pregnancy; Pregnancy Complications, Infectious; Premature Birth; Prenatal Care; Rural Population; Treatment Outcome; Vaginosis, Bacterial; Young Adult | 2018 |
Early clindamycin for bacterial vaginosis in pregnancy (PREMEVA): a multicentre, double-blind, randomised controlled trial.
Topics: Abortion, Spontaneous; Adult; Anti-Bacterial Agents; Clindamycin; Double-Blind Method; Female; Humans; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Premature Birth; Vaginosis, Bacterial | 2018 |
Continuous versus interrupted use of vaginal probiotics plus vaginal clindamycin cream for bacterial vaginosis: a randomized controlled study.
Topics: Administration, Intravaginal; Anti-Bacterial Agents; Clindamycin; Double-Blind Method; Female; Humans; Neoplasm Recurrence, Local; Probiotics; Treatment Outcome; Vaginal Creams, Foams, and Jellies; Vaginosis, Bacterial | 2021 |
[Probiotic monotherapy of bacterial vaginosis: a open, randomized trial].
Topics: Administration, Intravaginal; Administration, Oral; Adolescent; Adult; Anti-Infective Agents; Clindamycin; Female; Humans; Lacticaseibacillus rhamnosus; Lactobacillus acidophilus; Metronidazole; Middle Aged; Probiotics; Treatment Outcome; Vagina; Vaginosis, Bacterial; Young Adult | 2013 |
Vaginal colonisation by probiotic lactobacilli and clinical outcome in women conventionally treated for bacterial vaginosis and yeast infection.
Topics: Administration, Intravaginal; Adult; Anti-Bacterial Agents; Antifungal Agents; Candidiasis, Vulvovaginal; Carrier State; Clindamycin; Drug Therapy, Combination; Female; Fluconazole; Humans; Lactobacillus; Metronidazole; Middle Aged; Probiotics; Treatment Outcome; Vagina; Vaginosis, Bacterial; Young Adult | 2015 |
Effect of clindamycin treatment on vaginal inflammatory markers in pregnant women with bacterial vaginosis and a positive fetal fibronectin test.
Topics: Adult; Anti-Bacterial Agents; Clindamycin; Cohort Studies; Female; Fibronectins; Humans; Inflammation; Interleukin-1beta; Interleukin-6; Matrix Metalloproteinase 8; Pregnancy; Pregnancy Complications, Infectious; Premature Birth; Prospective Studies; Vagina; Vaginosis, Bacterial; Young Adult | 2009 |
Comparative efficacy of probiotic yoghurt and clindamycin in treatment of bacterial vaginosis in pregnant women: a randomized clinical trial.
Topics: Adult; Anti-Bacterial Agents; Clindamycin; Double-Blind Method; Female; Humans; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Trimester, Third; Premature Birth; Probiotics; Treatment Outcome; Vaginosis, Bacterial; Yogurt; Young Adult | 2012 |
[Evaluation of efficacy of ketoconazole 800 mg-clindamycin 100 mg tablets vaginal against ketoconazole 800 mg- clindamycin 100 mg vaginal capsules in candida vaginitis and vaginosis].
Topics: Actinomycetales Infections; Administration, Intravaginal; Adolescent; Adult; Candida albicans; Candidiasis, Vulvovaginal; Capsules; Clindamycin; Drug Therapy, Combination; Female; Gardnerella vaginalis; Humans; Ketoconazole; Middle Aged; Mobiluncus; Patient Acceptance of Health Care; Tablets; Vaginosis, Bacterial; Young Adult | 2011 |
A comparison of dequalinium chloride vaginal tablets (Fluomizin®) and clindamycin vaginal cream in the treatment of bacterial vaginosis: a single-blind, randomized clinical trial of efficacy and safety.
Topics: Adolescent; Adult; Candidiasis, Vulvovaginal; Clindamycin; Dequalinium; Female; Follow-Up Studies; Humans; Middle Aged; Single-Blind Method; Treatment Outcome; Vaginal Creams, Foams, and Jellies; Vaginosis, Bacterial; Young Adult | 2012 |
Efficacy of oral metronidazole with vaginal clindamycin or vaginal probiotic for bacterial vaginosis: randomised placebo-controlled double-blind trial.
Topics: Administration, Intravaginal; Administration, Oral; Adolescent; Adult; Anti-Bacterial Agents; Clindamycin; Double-Blind Method; Female; Follow-Up Studies; Humans; Medication Adherence; Metronidazole; Middle Aged; Placebos; Probiotics; Recurrence; Self Report; Time Factors; Treatment Outcome; Vaginal Creams, Foams, and Jellies; Vaginosis, Bacterial; Young Adult | 2012 |
Rescreening for abnormal vaginal flora in pregnancy and re-treating with clindamycin vaginal cream significantly increases cure and improvement rates.
Topics: Anti-Bacterial Agents; Clindamycin; Double-Blind Method; Female; Humans; Pregnancy; Pregnancy Complications, Infectious; Secondary Prevention; Treatment Outcome; Vagina; Vaginal Creams, Foams, and Jellies; Vaginosis, Bacterial | 2012 |
Recurrence of bacterial vaginosis is significantly associated with posttreatment sexual activities and hormonal contraceptive use.
Topics: Administration, Intravaginal; Administration, Oral; Adolescent; Adult; Anti-Infective Agents; Australia; Clindamycin; Contraceptive Agents; Double-Blind Method; Female; Humans; Metronidazole; Middle Aged; Placebos; Probiotics; Recurrence; Risk Factors; Sexual Behavior; Vaginosis, Bacterial; Young Adult | 2013 |
[Clindamycin soluble suppository-production and its efficacy in treating bacterial vaginosis].
Topics: Administration, Intravaginal; Animals; Anti-Infective Agents; Clindamycin; Female; Humans; Rabbits; Rats; Rats, Sprague-Dawley; Suppositories; Vaginosis, Bacterial | 2001 |
Relation between Gram-stain and clinical criteria for diagnosing bacterial vaginosis with special reference to Gram grade II evaluation.
Topics: Bacteria; Body Fluids; Clindamycin; Female; Gentian Violet; Gram-Negative Bacterial Infections; Humans; Phenazines; Pregnancy; Pregnancy Complications, Infectious; Staining and Labeling; Vaginal Smears; Vaginosis, Bacterial | 2003 |
Effect of early oral clindamycin on late miscarriage and preterm delivery in asymptomatic women with abnormal vaginal flora and bacterial vaginosis: a randomised controlled trial.
Topics: Abortion, Spontaneous; Administration, Oral; Adult; Anti-Bacterial Agents; Clindamycin; Female; Humans; Obstetric Labor, Premature; Pregnancy; Pregnancy Outcome; Vaginal Smears; Vaginosis, Bacterial | 2003 |
Efficacy of the combination of 2 g oral tinidazole and acidic buffering vaginal gel in comparison with vaginal clindamycin alone in bacterial vaginosis: a randomized, investigator-blinded, controlled trial.
Topics: Administration, Intravaginal; Adult; Aged; Anti-Bacterial Agents; Buffers; Clindamycin; Female; Gels; Humans; Hydrogen-Ion Concentration; Middle Aged; Prospective Studies; Recurrence; Tinidazole; Treatment Outcome; Vaginosis, Bacterial | 2003 |
Treatment of asymptomatic bacterial vaginosis to prevent pre-term delivery: a randomised trial.
Topics: Anti-Bacterial Agents; Birth Weight; Clindamycin; Female; Fetal Membranes, Premature Rupture; Gestational Age; Humans; Obstetric Labor, Premature; Pregnancy; Treatment Outcome; Vaginosis, Bacterial | 2003 |
The efficacy of vaginal clindamycin for the treatment of abnormal genital tract flora in pregnancy.
Topics: Administration, Intravaginal; Adolescent; Adult; Chi-Square Distribution; Clindamycin; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Probability; Prospective Studies; Reference Values; Risk Assessment; Treatment Outcome; Vaginal Creams, Foams, and Jellies; Vaginal Smears; Vaginosis, Bacterial | 2003 |
Natural history of bacterial vaginosis and intermediate flora in pregnancy and effect of oral clindamycin.
Topics: Administration, Oral; Anti-Bacterial Agents; Clindamycin; Female; Humans; Pregnancy; Pregnancy Complications, Infectious; Recurrence; Vagina; Vaginosis, Bacterial | 2004 |
Efficient prematurity prevention is possible by pH-self measurement and immediate therapy of threatening ascending infection.
Topics: Administration, Intravaginal; Anti-Bacterial Agents; Clindamycin; Female; Germany; Humans; Hydrogen-Ion Concentration; Infant, Newborn; Infant, Premature; Lactobacillus acidophilus; Obstetric Labor, Premature; Pregnancy; Pregnancy Complications, Infectious; Probiotics; Prospective Studies; Self Care; Treatment Outcome; Vagina; Vaginosis, Bacterial | 2004 |
Antimicrobial resistance associated with the treatment of bacterial vaginosis.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Clindamycin; Drug Resistance, Bacterial; Female; Humans; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Vaginosis, Bacterial | 2004 |
A double-blind treatment study of bacterial vaginosis with normal vaginal lactobacilli after an open treatment with vaginal clindamycin ovules.
Topics: Administration, Intravaginal; Adolescent; Adult; Anti-Bacterial Agents; Clindamycin; Double-Blind Method; Female; Humans; Lactobacillus; Menstrual Hygiene Products; Middle Aged; Probiotics; Treatment Outcome; Vaginal Smears; Vaginosis, Bacterial | 2005 |
Microbiologic response to treatment of bacterial vaginosis with topical clindamycin or metronidazole.
Topics: Administration, Topical; Adolescent; Adult; Anti-Bacterial Agents; Bacteroidaceae; Bacteroidaceae Infections; Clindamycin; Drug Resistance, Bacterial; Female; Humans; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Treatment Outcome; Vagina; Vaginosis, Bacterial | 2005 |
The efficacy and safety of a single dose of Clindesse vaginal cream versus a seven-dose regimen of Cleocin vaginal cream in patients with bacterial vaginosis.
Topics: Administration, Intravaginal; Adult; Anti-Bacterial Agents; Clindamycin; Female; Humans; Treatment Outcome; Vaginal Creams, Foams, and Jellies; Vaginosis, Bacterial | 2005 |
[Comparison of efficacy of combination of ketokonazol 400 mg + clindamycin 100 mg with ketokonazol 800 mg + clindamycin 100 mg in the treatment of vaginitis due to Candida and bacterial vaginosis].
Topics: Adolescent; Adult; Anti-Bacterial Agents; Antifungal Agents; Candidiasis; Clindamycin; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Ketoconazole; Middle Aged; Vaginitis; Vaginosis, Bacterial | 2005 |
Oral clindamycin and histologic chorioamnionitis in women with abnormal vaginal flora.
Topics: Abortion, Spontaneous; Administration, Oral; Adult; Biopsy, Needle; Chorioamnionitis; Clindamycin; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Gestational Age; Humans; Immunohistochemistry; Maternal Age; Middle Aged; Parity; Pregnancy; Pregnancy Outcome; Premature Birth; Probability; Reference Values; Risk Assessment; Severity of Illness Index; Treatment Outcome; Vaginosis, Bacterial | 2006 |
Late miscarriage and preterm birth after treatment with clindamycin: a randomised consent design study according to Zelen.
Topics: Abortion, Spontaneous; Adult; Anti-Bacterial Agents; Birth Weight; Clindamycin; Female; Humans; Infant, Newborn; Odds Ratio; Pregnancy; Pregnancy Outcome; Premature Birth; Statistics, Nonparametric; Survival Analysis; Treatment Outcome; Vaginosis, Bacterial | 2006 |
The effects of intravaginal clindamycin and metronidazole therapy on vaginal mobiluncus morphotypes in patients with bacterial vaginosis.
Topics: Actinomycetales Infections; Administration, Intravaginal; Adult; Anti-Bacterial Agents; Clindamycin; Female; Humans; Metronidazole; Mobiluncus; Retrospective Studies; Self Care; Treatment Outcome; Vaginosis, Bacterial | 2007 |
Treatment options for bacterial vaginosis in patients at high risk of preterm labor and premature rupture of membranes.
Topics: Administration, Intravaginal; Administration, Oral; Adult; Anti-Bacterial Agents; Clindamycin; Female; Fetal Membranes, Premature Rupture; Humans; Metronidazole; Obstetric Labor, Premature; Pregnancy; Pregnancy Trimester, Third; Risk Factors; Treatment Outcome; Vaginosis, Bacterial | 2007 |
Human lactobacilli as supplementation of clindamycin to patients with bacterial vaginosis reduce the recurrence rate; a 6-month, double-blind, randomized, placebo-controlled study.
Topics: Administration, Intravaginal; Administration, Oral; Adult; Anti-Bacterial Agents; Clindamycin; Combined Modality Therapy; Confidence Intervals; Double-Blind Method; Female; Follow-Up Studies; Humans; Lactobacillus; Middle Aged; Norway; Odds Ratio; Probiotics; Secondary Prevention; Vagina; Vaginosis, Bacterial; Women's Health | 2008 |
Bacterial vaginosis.
Topics: Antitrichomonal Agents; Clindamycin; Female; Gardnerella vaginalis; Humans; Metronidazole; Vaginosis, Bacterial | 1995 |
Intravaginal clindamycin treatment for bacterial vaginosis: effects on preterm delivery and low birth weight.
Topics: Administration, Intravaginal; Adult; Age Factors; Anti-Bacterial Agents; Clindamycin; Double-Blind Method; Female; Gestational Age; Humans; Infant, Low Birth Weight; Infant, Newborn; Infant, Premature; Parity; Placebos; Pregnancy; Pregnancy Complications, Infectious; Vaginosis, Bacterial | 1995 |
Absorption of clindamycin after intravaginal application of clindamycin phosphate 2% cream.
Topics: Absorption; Administration, Intravaginal; Adult; Anti-Bacterial Agents; Biological Availability; Chromatography, Gas; Clindamycin; Female; Humans; Infusions, Intravenous; Middle Aged; Ointments; Vaginosis, Bacterial | 1995 |
The treatment of bacterial vaginosis with a 3 day course of 2% clindamycin cream: results of a multicentre, double blind, placebo controlled trial. B V Investigators Group.
Topics: Administration, Intravaginal; Adolescent; Adult; Aminoglycosides; Anti-Bacterial Agents; Clindamycin; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Ointments; Prospective Studies; Treatment Outcome; Vaginosis, Bacterial | 1995 |
Treatment of bacterial vaginosis: a comparison of oral metronidazole, metronidazole vaginal gel, and clindamycin vaginal cream.
Topics: Administration, Intravaginal; Administration, Oral; Adolescent; Adult; Anti-Bacterial Agents; Candidiasis, Vulvovaginal; Clindamycin; DNA Probes; Drug Administration Schedule; Female; Gardnerella vaginalis; Gels; Humans; Metronidazole; Middle Aged; Pregnancy; Vaginosis, Bacterial | 1995 |
[New alternatives in the treatment of bacterial vaginosis].
Topics: Administration, Oral; Adolescent; Adult; Clindamycin; Double-Blind Method; Female; Follow-Up Studies; Humans; Metronidazole; Middle Aged; Vaginal Creams, Foams, and Jellies; Vaginosis, Bacterial | 1994 |
Bacterial vaginosis-associated microflora and effects of topical intravaginal clindamycin.
Topics: Administration, Intravaginal; Clindamycin; Colony Count, Microbial; Double-Blind Method; Female; Humans; Mycoses; Vaginosis, Bacterial | 1994 |
Bacterial vaginosis is associated with prematurity and vaginal fluid mucinase and sialidase: results of a controlled trial of topical clindamycin cream.
Topics: Administration, Topical; Adolescent; Adult; Clindamycin; Double-Blind Method; Female; Humans; Middle Aged; Neuraminidase; Obstetric Labor, Premature; Polysaccharide-Lyases; Pregnancy; Pregnancy Complications, Infectious; Prospective Studies; Vagina; Vaginosis, Bacterial | 1994 |
Treatment of bacterial vaginosis with a three day course of 2% clindamycin vaginal cream: a pilot study.
Topics: Adolescent; Adult; Clindamycin; Double-Blind Method; Drug Administration Schedule; Female; Humans; Pilot Projects; Prospective Studies; Treatment Outcome; Vaginal Creams, Foams, and Jellies; Vaginosis, Bacterial | 1994 |
Placebo-controlled trial of intravaginal clindamycin 2% cream for the treatment of bacterial vaginosis.
Topics: Administration, Intravaginal; Adolescent; Adult; Clindamycin; Double-Blind Method; Female; Humans; Middle Aged; Ointments; Remission Induction; Risk Factors; Vaginosis, Bacterial | 1993 |
Efficacy of clindamycin vaginal cream versus oral metronidazole in the treatment of bacterial vaginosis.
Topics: Administration, Intravaginal; Administration, Oral; Clindamycin; Double-Blind Method; Female; Follow-Up Studies; Humans; Metronidazole; Vaginosis, Bacterial | 1993 |
Long-term follow-up of patients with bacterial vaginosis treated with oral metronidazole and topical clindamycin.
Topics: Administration, Oral; Administration, Topical; Clindamycin; Female; Follow-Up Studies; Humans; Metronidazole; Vaginosis, Bacterial | 1993 |
Treatment of male partners and recurrence of bacterial vaginosis: a randomised trial.
Topics: Administration, Intravaginal; Administration, Oral; Adolescent; Adult; Anti-Bacterial Agents; Clindamycin; Double-Blind Method; Female; Humans; Male; Middle Aged; Recurrence; Sexual Partners; Treatment Outcome; Vaginosis, Bacterial | 1997 |
[Therapy of bacterial vaginosis. Prospective clinical study ot the efficacy and tolerability of quaternary ammonium salts vs. clindamycin].
Topics: Adolescent; Adult; Anti-Bacterial Agents; Clindamycin; Female; Humans; Prospective Studies; Quaternary Ammonium Compounds; Vaginosis, Bacterial | 1998 |
Insulin-like growth factor binding protein-1 in cervix as a marker of infectious complications in pregnant women with bacterial vaginosis.
Topics: Anti-Bacterial Agents; Biomarkers; Cervix Uteri; Clindamycin; Double-Blind Method; Female; Humans; Insulin-Like Growth Factor Binding Protein 1; Pregnancy; Pregnancy Complications, Infectious; Vaginosis, Bacterial | 1999 |
[Therapeutic regimens for treating bacterial vaginosis in pregnant women].
Topics: Administration, Intravaginal; Adolescent; Adult; Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Clindamycin; Clinical Protocols; Female; Humans; Metronidazole; Middle Aged; Penicillins; Pregnancy; Pregnancy Complications, Infectious; Retrospective Studies; Vaginosis, Bacterial | 1999 |
Treatment with 2% clindamycin vaginal cream prior to first trimester surgical abortion to reduce signs of postoperative infection: a prospective, double-blinded, placebo-controlled, multicenter study.
Topics: Abortion, Induced; Administration, Topical; Adult; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacterial Infections; Clindamycin; Double-Blind Method; Female; Humans; Postoperative Complications; Pregnancy; Pregnancy Trimester, First; Vagina; Vaginosis, Bacterial | 2000 |
Vaginal clindamycin and oral metronidazole for bacterial vaginosis: a randomized trial.
Topics: Administration, Intravaginal; Administration, Oral; Adolescent; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Clindamycin; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Europe; Female; Humans; Metronidazole; Middle Aged; Vaginosis, Bacterial | 2000 |
[The treatment of bacterial vaginosis with Dalacin V cream].
Topics: Adult; Anti-Bacterial Agents; Clindamycin; Female; Humans; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Trimester, First; Recurrence; Time Factors; Vaginal Creams, Foams, and Jellies; Vaginosis, Bacterial | 2000 |
Effect of intravaginal clindamycin cream on pregnancy outcome and on abnormal vaginal microbial flora of pregnant women.
Topics: Adult; Anti-Bacterial Agents; Bacteria; Clindamycin; Cohort Studies; Double-Blind Method; Female; Humans; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Prospective Studies; Vagina; Vaginal Creams, Foams, and Jellies; Vaginosis, Bacterial | 2000 |
A randomised controlled trial of vaginal clindamycin for early pregnancy bacterial vaginosis.
Topics: Administration, Intravaginal; Adult; Anti-Bacterial Agents; Clindamycin; Female; Gardnerella; Humans; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Pregnancy Trimester, First; Treatment Outcome; Vaginosis, Bacterial | 2000 |
Vaginal clindamycin in preventing preterm birth and peripartal infections in asymptomatic women with bacterial vaginosis: a randomized, controlled trial.
Topics: Administration, Intravaginal; Clindamycin; Double-Blind Method; Female; Follow-Up Studies; Humans; Mass Screening; Obstetric Labor, Premature; Postpartum Period; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Pregnancy Trimester, First; Risk Assessment; Severity of Illness Index; Treatment Outcome; Vaginal Smears; Vaginosis, Bacterial | 2001 |
Efficacy of clindamycin vaginal ovule (3-day treatment) vs. clindamycin vaginal cream (7-day treatment) in bacterial vaginosis.
Topics: Administration, Intravaginal; Adolescent; Adult; Anti-Bacterial Agents; Clindamycin; Drug Administration Schedule; Female; Humans; Middle Aged; Prospective Studies; Statistics, Nonparametric; Vaginal Creams, Foams, and Jellies; Vaginosis, Bacterial | 2001 |
Changes in the vaginal flora after two percent clindamycin vaginal cream in women at high risk of spontaneous preterm birth.
Topics: Administration, Intravaginal; Adult; Anti-Bacterial Agents; Clindamycin; Contraindications; Double-Blind Method; Female; Humans; Obstetric Labor, Premature; Pregnancy; Treatment Outcome; Vagina; Vaginal Creams, Foams, and Jellies; Vaginosis, Bacterial | 2001 |
Comparison of clindamycin phosphate vaginal cream with triple sulfonamide vaginal cream in the treatment of bacterial vaginosis.
Topics: Administration, Intravaginal; Adolescent; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Clindamycin; Double-Blind Method; Female; Follow-Up Studies; Humans; Middle Aged; Recurrence; Sulfonamides; Treatment Outcome; Vaginal Creams, Foams, and Jellies; Vaginosis, Bacterial | 2001 |
Clindamycin vaginal cream versus oral metronidazole in the treatment of bacterial vaginosis: a prospective double-blind clinical trial.
Topics: Administration, Intravaginal; Administration, Oral; Adolescent; Adult; Clindamycin; Double-Blind Method; Female; Humans; Metronidazole; Middle Aged; Ointments; Prospective Studies; Vaginosis, Bacterial | 1992 |
Bacterial vaginosis: treatment with clindamycin cream versus oral metronidazole.
Topics: Administration, Oral; Adult; Clindamycin; Double-Blind Method; Female; Humans; Metronidazole; Middle Aged; Prospective Studies; Vaginal Creams, Foams, and Jellies; Vaginosis, Bacterial | 1992 |
Adjunctive clindamycin therapy for preterm labor: results of a double-blind, placebo-controlled trial.
Topics: Chemotherapy, Adjuvant; Clindamycin; Double-Blind Method; Female; Humans; Obstetric Labor, Premature; Pregnancy; Pregnancy Complications, Infectious; Vaginosis, Bacterial | 1991 |
55 other study(ies) available for clindamycin and Bacterial Vaginitides
| Article | Year |
|---|---|
In vitro interactions within a biofilm containing three species found in bacterial vaginosis (BV) support the higher antimicrobial tolerance associated with BV recurrence.
Topics: Actinobacteria; Anti-Bacterial Agents; Anti-Infective Agents; Bacteria; Biofilms; Clindamycin; Female; Gardnerella vaginalis; Humans; In Situ Hybridization, Fluorescence; Metronidazole; Vagina; Vaginosis, Bacterial | 2022 |
Addressing the challenges with bacterial vaginosis pharmacotherapy.
Topics: Anti-Bacterial Agents; Clindamycin; Female; Humans; Metronidazole; Vaginosis, Bacterial | 2023 |
Single-Dose Clindamycin Gel Highly Effective for Bacterial Vaginosis.
Topics: Administration, Intravaginal; Anti-Bacterial Agents; Clindamycin; Female; Humans; Vaginal Creams, Foams, and Jellies; Vaginosis, Bacterial | 2022 |
The vaginal microbiota in the course of bacterial vaginosis treatment.
Topics: Adult; Anti-Bacterial Agents; Bacteria; Clindamycin; Female; Host Specificity; Humans; Metronidazole; Microbiota; RNA, Ribosomal, 16S; Vagina; Vaginal Discharge; Vaginosis, Bacterial | 2021 |
Limitations of treating pregnant women based solely on vaginal pH.
Topics: Clindamycin; Female; Humans; Hydrogen-Ion Concentration; Infant, Newborn; Pregnancy; Premature Birth; Vagina; Vaginosis, Bacterial | 2018 |
Author's reply re: Clindamycin to reduce preterm birth in a low resource setting: a randomised placebo-controlled clinical trial.
Topics: Clindamycin; Female; Humans; Infant, Newborn; Obstetric Labor, Premature; Pregnancy; Premature Birth; Vaginosis, Bacterial | 2018 |
Re: Clindamycin to reduce preterm birth in a low resource setting: a randomised placebo-controlled clinical trial.
Topics: Clindamycin; Female; Humans; Infant, Newborn; Obstetric Labor, Premature; Pregnancy; Premature Birth; Vaginosis, Bacterial | 2018 |
Treatment of bacterial vaginosis to prevent preterm birth.
Topics: Clindamycin; Double-Blind Method; Female; Humans; Infant, Newborn; Pregnancy; Pregnancy Complications, Infectious; Premature Birth; Vaginosis, Bacterial | 2018 |
The Natural Antimicrobial Subtilosin A Synergizes with Lauramide Arginine Ethyl Ester (LAE), ε-Poly-L-lysine (Polylysine), Clindamycin Phosphate and Metronidazole, Against the Vaginal Pathogen Gardnerella vaginalis.
Topics: Anti-Infective Agents; Arginine; Bacteriocins; Biofilms; Clindamycin; Drug Resistance, Multiple, Bacterial; Drug Synergism; Female; Gardnerella vaginalis; Humans; Lactobacillus; Metronidazole; Microbial Sensitivity Tests; Peptides, Cyclic; Polylysine; Vagina; Vaginosis, Bacterial | 2015 |
Vulvovaginitis: screening for and management of trichomoniasis, vulvovaginal candidiasis, and bacterial vaginosis.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Canada; Candidiasis, Vulvovaginal; Clindamycin; Female; Humans; MEDLINE; Metronidazole; Pregnancy; Pregnancy Complications, Infectious; Premature Birth; Recurrence; Sexually Transmitted Diseases; Trichomonas Vaginitis; Vaginosis, Bacterial; Vulvovaginitis | 2015 |
[Bacterial vaginosis: efficacy of a local treatment with a gel containing a fraction derived from propinibacterium acnes].
Topics: Acrylic Resins; Administration, Intravaginal; Adolescent; Adult; Anti-Bacterial Agents; Clindamycin; Female; Humans; Hyaluronic Acid; Propionibacterium acnes; Treatment Outcome; Vaginal Creams, Foams, and Jellies; Vaginosis, Bacterial; Young Adult | 2016 |
The treatment of bacterial vaginosis in pregnancy with clindamycin to reduce the risk of infection-related preterm birth: a response to the Danish Society of Obstetrics and Gynecology guideline group's clinical recommendations.
Topics: Abortion, Spontaneous; Anti-Bacterial Agents; Clindamycin; Female; Humans; Infant, Low Birth Weight; Infant, Newborn; Metronidazole; Practice Guidelines as Topic; Pregnancy; Pregnancy Complications, Infectious; Premature Birth; Research Design; Vaginosis, Bacterial | 2017 |
[Vaginal infections associated with bacterial vaginosis and periodontal disease--effective diagnostic and therapeutic possibilities].
Topics: Anti-Bacterial Agents; Clindamycin; Congresses as Topic; Drug Therapy, Combination; Female; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Metronidazole; Microscopy; Nystatin; Periodontitis; Pregnancy; Pregnancy Complications, Infectious; Risk Factors; Sulfamethazine; Sulfonamides; Time Factors; Vaginosis, Bacterial | 2008 |
Use of antibiotics in the treatment for bacterial vaginosis.
Topics: Anti-Bacterial Agents; Clindamycin; Female; Humans; Practice Guidelines as Topic; United Kingdom; Vaginosis, Bacterial | 2009 |
The efficacy of retreatment with the same medication for early treatment failure of bacterial vaginosis.
Topics: Administration, Topical; Adult; Anti-Bacterial Agents; Clindamycin; Cohort Studies; Drug Administration Schedule; Female; Humans; Metronidazole; Recurrence; Treatment Failure; Treatment Outcome; Vaginosis, Bacterial | 2009 |
[Bacterial vaginosis -- treatment C "Dalacin V" cream].
Topics: Anti-Bacterial Agents; Clindamycin; Female; Humans; Metronidazole; Pregnancy; Vaginal Creams, Foams, and Jellies; Vaginosis, Bacterial | 2002 |
Treatment considerations for bacterial vaginosis and the risk of recurrence.
Topics: Administration, Intravaginal; Administration, Oral; Adolescent; Adult; Anti-Bacterial Agents; Candidiasis, Vulvovaginal; Clindamycin; Drug Administration Schedule; Female; Humans; Metronidazole; Middle Aged; Risk Factors; Secondary Prevention; Treatment Outcome; United States; Vagina; Vaginosis, Bacterial; Women's Health; Young Adult | 2009 |
In vitro activity of nifuratel on vaginal bacteria: could it be a good candidate for the treatment of bacterial vaginosis?
Topics: Anti-Bacterial Agents; Clindamycin; Female; Humans; Metronidazole; Microbial Sensitivity Tests; Nifuratel; Vagina; Vaginosis, Bacterial | 2011 |
Vaginal retention of locally administered clindamycin.
Topics: Administration, Intravaginal; Adult; Anti-Bacterial Agents; Clindamycin; Drug Therapy, Combination; Female; Humans; Lactobacillus; Middle Aged; Probiotics; Prospective Studies; Treatment Outcome; Vagina; Vaginosis, Bacterial | 2011 |
Extended antimicrobial treatment of bacterial vaginosis combined with human lactobacilli to find the best treatment and minimize the risk of relapses.
Topics: Adult; Anti-Infective Agents; Clindamycin; Female; Humans; Lactobacillus; Metronidazole; Middle Aged; Probiotics; Secondary Prevention; Treatment Outcome; Vaginosis, Bacterial | 2011 |
[Antibiotic resistance of Gardnerella vaginalis isolated from cases of bacterial vaginosis].
Topics: Administration, Intravaginal; Administration, Oral; Adult; Amoxicillin-Potassium Clavulanate Combination; Anti-Infective Agents; Bacterial Typing Techniques; Clindamycin; Drug Resistance, Bacterial; Female; Gardnerella vaginalis; Humans; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Poland; Vagina; Vaginosis, Bacterial; Young Adult | 2011 |
Susceptibility testing of Atopobium vaginae for dequalinium chloride.
Topics: Actinobacteria; Anti-Bacterial Agents; Bacteroides fragilis; Clindamycin; Culture Media; Dequalinium; Female; Humans; Metronidazole; Microbial Sensitivity Tests; Vagina; Vaginosis, Bacterial | 2012 |
[Susceptibility to antibiotics of microorganisms related with recurrent bacterial vaginosis].
Topics: Actinobacteria; Adult; Anti-Bacterial Agents; Clindamycin; Female; Gardnerella vaginalis; Humans; Lactobacillus; Metronidazole; Vagina; Vaginosis, Bacterial | 2011 |
Editorial commentary: Sexual networks, sex hormones, and recurrent bacterial vaginosis: not such strange bedfellows.
Topics: Anti-Infective Agents; Clindamycin; Contraceptive Agents; Female; Humans; Metronidazole; Probiotics; Sexual Behavior; Vaginosis, Bacterial | 2013 |
[Management of patients with a history of late abortion or very premature delivery].
Topics: Abortion, Spontaneous; Anti-Bacterial Agents; Cerclage, Cervical; Clindamycin; Female; Gestational Age; Humans; Obstetric Labor, Premature; Pregnancy; Premature Birth; Progesterone; Recurrence; Ultrasonography; Uterine Cervical Incompetence; Vaginosis, Bacterial | 2013 |
Indications for therapy and treatment recommendations for bacterial vaginosis in nonpregnant and pregnant women: a synthesis of data.
Topics: Anti-Infective Agents; Clindamycin; Drug Therapy; Female; Humans; Metronidazole; Obstetric Labor, Premature; Pregnancy; Pregnancy Outcome; Vaginosis, Bacterial | 2002 |
Effect of oral clindamycin on late miscarriage and preterm delivery.
Topics: Abortion, Spontaneous; Anti-Bacterial Agents; Clindamycin; Female; Humans; Obstetric Labor, Premature; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Vaginosis, Bacterial | 2003 |
Effect of oral clindamycin on late miscarriage and preterm delivery.
Topics: Abortion, Spontaneous; Anti-Bacterial Agents; Clindamycin; Female; Humans; Obstetric Labor, Premature; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Vaginosis, Bacterial | 2003 |
Changes in vaginal flora after 2% clindamycin vaginal cream in women at high risk of preterm birth.
Topics: Administration, Intravaginal; Anti-Bacterial Agents; Clindamycin; Contraindications; Female; Humans; Obstetric Labor, Premature; Pregnancy; Risk Factors; Vagina; Vaginal Creams, Foams, and Jellies; Vaginosis, Bacterial | 2003 |
Bacterial vaginosis in pregnancy: diagnosis and treatment practices of physicians in San Diego, California, 1999.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; California; Clindamycin; Cross-Sectional Studies; Female; Health Knowledge, Attitudes, Practice; Humans; Metronidazole; Obstetric Labor, Premature; Obstetrics; Physicians, Family; Practice Patterns, Physicians'; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Trimester, First; Vaginosis, Bacterial | 2003 |
[Efficient prevention of prematurity - the Thuringian model].
Topics: Anti-Bacterial Agents; Birth Weight; Clindamycin; Female; Germany; Gestational Age; Humans; Hydrogen-Ion Concentration; Infant, Newborn; Infant, Premature; Obstetric Labor, Premature; Pregnancy; Prospective Studies; Risk Factors; Self Care; Vagina; Vaginal Creams, Foams, and Jellies; Vaginosis, Bacterial | 2004 |
Cost-effectiveness of screening and treatment for bacterial vaginosis in early pregnancy among women at low risk for preterm birth.
Topics: Anti-Infective Agents; Clindamycin; Cost-Benefit Analysis; Decision Trees; Diagnosis-Related Groups; Female; Finland; Humans; Metronidazole; Models, Economic; Obstetric Labor, Premature; Outcome Assessment, Health Care; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Prenatal Diagnosis; Vaginosis, Bacterial | 2004 |
Natural history of bacterial vaginosis and intermediate flora in pregnancy and effect of oral clindamycin.
Topics: Anti-Bacterial Agents; Candidiasis; Clindamycin; Disease Progression; Female; Gestational Age; Humans; Infant, Newborn; Pregnancy; Pregnancy Complications, Infectious; Sepsis; Vaginosis, Bacterial | 2004 |
[Bacterial vaginosis in pregnant women--treatment with clindamycin].
Topics: Administration, Intravaginal; Anti-Bacterial Agents; Clindamycin; Female; Humans; Pregnancy; Pregnancy Complications, Infectious; Vaginosis, Bacterial | 2004 |
The effects of intravaginal clindamycin and metronidazole therapy on vaginal lactobacilli in patients with bacterial vaginosis.
Topics: Administration, Intravaginal; Adult; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Clindamycin; Colony Count, Microbial; Drug Therapy, Combination; Female; Humans; Lactobacillus; Metronidazole; Middle Aged; Retrospective Studies; Time Factors; Vagina; Vaginosis, Bacterial | 2006 |
Comment on "Pregnancy outcome after early detection of bacterial vaginosis" [Eur. J. Obstet. Gynecol. Reprod. Biol. 128 (2006) 40-45].
Topics: Adult; Animals; Antiprotozoal Agents; Clindamycin; Female; Humans; Infant, Newborn; Metronidazole; Pregnancy; Pregnancy Complications, Infectious; Premature Birth; Trichomonas vaginalis; Vaginosis, Bacterial | 2007 |
[Biotypes and antibiotic resistance patterns of Gardnerella vaginalis strains isolated from healthy women and women with bacterial vaginosis].
Topics: Anti-Infective Agents; Bacterial Typing Techniques; Case-Control Studies; Clindamycin; Drug Resistance, Bacterial; Female; Gardnerella vaginalis; Humans; Metronidazole; Microbial Sensitivity Tests; Vagina; Vaginosis, Bacterial | 2007 |
Predisposing factors for bacterial vaginosis, treatment efficacy and pregnancy outcome among term deliveries; results from a preterm delivery study.
Topics: Adult; Anti-Bacterial Agents; Clindamycin; Female; Humans; Logistic Models; Mass Screening; Obstetric Labor, Premature; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Prevalence; Prospective Studies; Risk Factors; Sweden; Treatment Outcome; Vaginal Creams, Foams, and Jellies; Vaginal Smears; Vaginosis, Bacterial | 2007 |
Quantitative determination by real-time PCR of four vaginal Lactobacillus species, Gardnerella vaginalis and Atopobium vaginae indicates an inverse relationship between L. gasseri and L. iners.
Topics: Actinobacteria; Adolescent; Adult; Anti-Bacterial Agents; Clindamycin; DNA Primers; Ecosystem; Female; Gardnerella vaginalis; Gentian Violet; Humans; Lactobacillus; Middle Aged; Phenazines; Polymerase Chain Reaction; Pregnancy; Pregnancy Complications, Infectious; RNA, Ribosomal, 16S; Sequence Alignment; Vagina; Vaginosis, Bacterial | 2007 |
Antibiotics for the prevention of preterm birth.
Topics: Anti-Infective Agents; Antibiotic Prophylaxis; Clindamycin; Female; Humans; Meta-Analysis as Topic; Metronidazole; Pregnancy; Pregnancy Complications, Infectious; Premature Birth; Vaginosis, Bacterial | 2008 |
A mixed approach for proving non-inferiority in clinical trials with binary endpoints.
Topics: Anti-Bacterial Agents; Clindamycin; Data Interpretation, Statistical; Endpoint Determination; Female; Humans; Odds Ratio; Randomized Controlled Trials as Topic; Sample Size; Therapeutic Equivalency; Vaginosis, Bacterial | 2008 |
Body odour.
Topics: Body Fluids; Clindamycin; Female; Genitalia, Male; Humans; Male; Metronidazole; Odorants; Vagina; Vaginosis, Bacterial | 1995 |
[Gardnerella vaginalis: transport, microscopy, testing resistance].
Topics: Bacteriological Techniques; Clindamycin; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Erythromycin; Female; Gardnerella vaginalis; Humans; Metronidazole; Microbial Sensitivity Tests; Specimen Handling; Vaginal Smears; Vaginosis, Bacterial | 1994 |
The potential effect on Neisseria gonorrhoeae of the use of clindamycin vaginal cream in the empirical treatment of vaginal discharge.
Topics: Anti-Bacterial Agents; Clindamycin; Female; Gonorrhea; Humans; Neisseria gonorrhoeae; Vaginosis, Bacterial | 1995 |
[Bacterial vaginosis. Relation between the vaginal flora and the vaginal epithelial cells under different treatments. Ultrastructural study].
Topics: Adult; Anti-Bacterial Agents; Clindamycin; Epithelial Cells; Epithelium; Female; Humans; Metronidazole; Middle Aged; Vagina; Vaginosis, Bacterial | 1997 |
Therapy of bacterial vaginosis.
Topics: Antitrichomonal Agents; Bacteroides; Bacteroides Infections; Clindamycin; Drug Therapy, Combination; Erythromycin; Female; Gardnerella vaginalis; Humans; Metronidazole; Mycoplasma hominis; Mycoplasma Infections; Pregnancy; Pregnancy Complications; Sexually Transmitted Diseases; Vaginosis, Bacterial | 1998 |
Clostridium difficile toxin-induced colitis after use of clindamycin phosphate vaginal cream.
Topics: Adult; Anti-Bacterial Agents; Bacterial Toxins; Clindamycin; Clostridioides difficile; Colitis; Diarrhea; Enterocolitis, Pseudomembranous; Enterotoxins; Female; Humans; Vaginal Creams, Foams, and Jellies; Vaginosis, Bacterial | 1998 |
[Bacterial vaginosis: where are we?].
Topics: Adolescent; Adult; Anti-Bacterial Agents; Bacteria; Clindamycin; Female; Gardnerella vaginalis; Humans; Middle Aged; Pregnancy; Pregnancy Complications, Infectious; Vagina; Vaginosis, Bacterial | 1998 |
Cost of bacterial vaginosis in pregnancy. Decision analysis and cost evaluation of a clinical study in Germany.
Topics: Administration, Intravaginal; Anti-Bacterial Agents; Clindamycin; Costs and Cost Analysis; Female; Germany; Gestational Age; Humans; Infant, Low Birth Weight; Infant, Newborn; Infant, Premature; Lactobacillus; Obstetric Labor, Premature; Pregnancy; Pregnancy Complications, Infectious; Vaginosis, Bacterial | 1999 |
National guideline for the management of bacterial vaginosis. Clinical Effectiveness Group (Association of Genitourinary Medicine and the Medical Society for the Study of Venereal Diseases).
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Clindamycin; Drug Administration Schedule; Female; Humans; Metronidazole; Pregnancy; Pregnancy Complications, Infectious; Vaginal Discharge; Vaginosis, Bacterial | 1999 |
[Application of 2% clindamycin cream in the treatment of bacterial vaginosis and valuation of methylcellulose gel containing the complex of Chitosan F and PVP k-90 with lactic acid as carrier for intravaginally adhbited medicines in the cases of pregnanci
Topics: Administration, Intravaginal; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Chitin; Chitosan; Clindamycin; Female; Gels; Humans; Lactic Acid; Methylcellulose; Obstetric Labor, Premature; Ointments; Pharmaceutic Aids; Povidone; Pregnancy; Pregnancy Complications, Infectious; Treatment Outcome; Vaginosis, Bacterial | 2001 |
Bacterial vaginosis during pregnancy. Should we screen for and treat it?
Topics: Anti-Infective Agents; Clindamycin; Female; Humans; Mass Screening; Metronidazole; Pregnancy; Pregnancy Complications, Infectious; Vaginosis, Bacterial | 2002 |
Topical treatment for bacterial vaginosis.
Topics: Administration, Intravaginal; Clindamycin; Female; Humans; Metronidazole; Vaginal Creams, Foams, and Jellies; Vaginosis, Bacterial | 1992 |
Report on Gardnerella vaginitis.
Topics: Ceftriaxone; Clindamycin; Female; Gardnerella vaginalis; Humans; Metronidazole; Military Personnel; Vaginosis, Bacterial | 1992 |
New concepts in bacterial vaginosis.
Topics: Clindamycin; Diagnosis, Differential; Female; Humans; Metronidazole; Trichomonas Vaginitis; Vaginosis, Bacterial | 1991 |